Triazolam pharmacokinetics and pharmacodynamics in caucasians and southern asians: Ethnicity and CYP3A activity

British Journal of Clinical Pharmacology

Volumn 41, Issue 1, 1996, Pages 69-72

  Kinirons, Mark T ^a   Lang, Chim C ^a   He, Huai B ^a   Ghebreselasie, Kebrab ^a   Shay, Sheila ^a   Robin, Deborah W ^a   Wood, Alastair J J ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

Cytochrome P450; Ethnic; Pharmacokinetics; Southern Asians; Triazolam

Indexed keywords

CYTOCHROME P450; PLACEBO; TRIAZOLAM;

ADULT; AREA UNDER THE CURVE; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; DRUG METABOLISM; ENZYME ACTIVITY; ETHNIC DIFFERENCE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACODYNAMICS; PHARMACOKINETICS; PRIORITY JOURNAL; SOUTH ASIA;

EID: 0030025732     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2125.1996.tb00160.x     Document Type: Article

References (14)

1. Wood AJJ, Zhou HH. Ethnic differences in drug disposition and responsiveness. Clin Pharmacokinet 1991; 20: 350-373.
2. Brian WR, Sari M-A, Iwasaki M, Marnett LJ, Guengerich FP. Catalytic activities of human liver cytochrome P-450 IIIA4 expressed in Saccharomyces cerevisiae. Biochemistry 1990; 29: 11280-11292.
3. Ashan CH, Renwick AG, Macklin B, Challenor VF, George CF. Ethnic differences in the pharmacokinetics of oral nifedipine. Br J Clin Pharmacol 1991; 31: 399-403.
4. Ashan CH, Renwick AG, Waller DG, Challenor VF, George CF, Amanullah M. The influence of dose and ethnic origins on pharmacokinetics of nifedipine. Clin Pharmacol Ther 1993; 54: 329-338.
5. Kronbach T, Mathys D, Umeno M, Gonzalez FJ, Meyer UA. Oxidation of midazolam and triazolam by human liver cytochrome P4503A4. Mol Pharmacol 1989; 36: 89-96.
6. Bailey DG, Spence JD, Munoz C, Arnold JMO. Interaction of citrus juices with felodipine and nifedipine. Lancet 1991; 337: 268-269.
7. Robin DR, MinHo L, Hasan SS, Wood AJJ. Triazolam in cirrhosis: pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther 1993; 54: 630-637.
8. Edeki T, Robin DR, Prakash C, Blair IA, Wood AJJ. Sensitive assay for triazolam in plasma following low oral doses. J Chromatogr 1992; 557: 190-194.
9. Kaminsky LS, Fasco MJ. Small intestinal cytochrome P450. Crit Rev Toxicol 1992; 21: 407-422.
10. Guengerich FP. Inhibition of oral contraceptive steroid-metabolizing enzyme by steroids and drugs. Am J Obstet Gynecol 1990; 163: 2159-2163.
11. Kolars JC, Merrion R, Awani WM, et al. First pass metabolism of cyclosporin by the gut. Lancet 1991; 338: 1488-1491.
12. Kolars JC, Schmiedlin-Ren P, Scheutz JD, Fang C, Watkins PB. Identification of rifampitin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes. J Clin Invest 1992; 90: 1871-1878.
13. Hoensch HP, Steinhardt HJ, Weiss G, Haug D, Maier A, Malchow H. Effects of semi synthetic diets on xenobiotics enzyme activity and morphology of small intestinal mucosa in humans. Gastroenterology 1984; 86: 1519-1530.
14. Ducharme MP, Provenzano R, Dehoorne-Smith M, Edwards DJ. Trough concentrations of cyclosporin in blood following administration with grapefruit juice. Br J Clin Pharmacol 1993; 36: 457-459.